Good morning,

China’s Orienspace just raised up to $124M to accelerate Gravity-2, a 70-meter reusable launcher designed to compete with CASC and Landspace in powering China’s mega-constellations. The move underscores how private capital is fueling a new generation of reusable rockets in Asia, where state and commercial actors alike are racing toward low-cost, high-capacity access to orbit.

In Russia, Roscosmos is pressing ahead with its Soyuz-5 test launch in December despite sanctions and funding shortfalls. The medium-class rocket (essentially a reincarnation of the Zenit-2) speaks to Moscow’s bid to maintain relevance in a launch market increasingly defined by reusability. Across the Atlantic, U.S. company Redwire secured a $25M NASA contract to expand microgravity drug research aboard the ISS, reinforcing biotech as a key driver of the emerging in-space economy.

More from today’s issue:
🛰️ CesiumAstro’s $10M Texas-backed spacecraft factory
⚡ Space Kinetic’s propellant-free “slingshot” deployment tech lands VC backing
🇨🇦 Canadensys to deliver Canada’s first lunar rover

P.S. Was this email forwarded to you? Sign up here.

SECTOR SITUATION REPORT

Orienspace Secures Fresh Funding to Advance Gravity-2 Reusable Rocket